Lv11
20 积分 2024-01-17 加入
GPR52 Antagonist Reduces Huntingtin Levels and Ameliorates Huntington’s Disease-Related Phenotypes
2小时前
待确认
Post-translational modifications orchestrate the intrinsic signaling bias of GPR52
8天前
已完结
Hijacking ERAD for targeted degradation of transmembrane proteins
1个月前
已完结
Bispecific antibodies: a mechanistic review of the pipeline
4个月前
已完结
Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
1年前
已完结
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
1年前
已完结
Optimal Structural Designs of Trispecific Antibodies to Enhance Therapeutic Efficacy in Solid Tumors and Hematological Malignancies
1年前
已完结
皖公网安备34019202002308
